Form 4: IGM Biosciences Director Elizabeth Thompson Acquires Shares as Part of Compensation

Director Elizabeth Thompson acquired 1,452 shares of IGM Biosciences common stock as part of a quarterly retainer payment.

Summary

• On June 28, 2024, Elizabeth H.Z. Thompson, a director of IGM Biosciences, acquired 1,452 shares of common stock.
• The acquisition was part of a partial payment of a quarterly retainer in common stock, according to the Issuer's Outside Director Compensation Policy.
• The price per share was $0.
• Following the transaction, Thompson directly owns 2,904 shares of IGM Biosciences common stock.
• The transaction was reported on July 2, 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock acquisition by a director as part of their compensation. It doesn't inherently indicate positive or negative sentiment, but rather a standard business practice.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Directors often receive stock as part of their compensation, aligning their interests with those of shareholders.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder confidence, as it demonstrates a director's investment in the company.

Key Dates